TW200726461A - Use of non-steroidal progesterone receptor modulators - Google Patents

Use of non-steroidal progesterone receptor modulators

Info

Publication number
TW200726461A
TW200726461A TW095122796A TW95122796A TW200726461A TW 200726461 A TW200726461 A TW 200726461A TW 095122796 A TW095122796 A TW 095122796A TW 95122796 A TW95122796 A TW 95122796A TW 200726461 A TW200726461 A TW 200726461A
Authority
TW
Taiwan
Prior art keywords
receptor modulators
progesterone receptor
steroidal progesterone
steroidal
hormone
Prior art date
Application number
TW095122796A
Other languages
English (en)
Inventor
Ulrike Fuhrmann
Carsten Moller
Norbert Schmees
Wolfgang Schwede
Anja Schmidt
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of TW200726461A publication Critical patent/TW200726461A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/536—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines ortho- or peri-condensed with carbocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Pain & Pain Management (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
TW095122796A 2005-06-24 2006-06-23 Use of non-steroidal progesterone receptor modulators TW200726461A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005030293A DE102005030293A1 (de) 2005-06-24 2005-06-24 Verwendung von nichtsteroidale Progesteronrezeptor-Modulatoren

Publications (1)

Publication Number Publication Date
TW200726461A true TW200726461A (en) 2007-07-16

Family

ID=37421093

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095122796A TW200726461A (en) 2005-06-24 2006-06-23 Use of non-steroidal progesterone receptor modulators

Country Status (12)

Country Link
US (1) US20060293317A1 (zh)
EP (1) EP1895999A1 (zh)
JP (1) JP2008543906A (zh)
AR (1) AR054803A1 (zh)
CA (1) CA2612161A1 (zh)
DE (1) DE102005030293A1 (zh)
DO (1) DOP2006000147A (zh)
GT (1) GT200600270A (zh)
PE (1) PE20070324A1 (zh)
TW (1) TW200726461A (zh)
UY (1) UY29625A1 (zh)
WO (1) WO2007022824A1 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30805A1 (es) * 2006-12-21 2008-07-31 Bayer Schering Pharma Ag Moduladores no esteroides de receptores de progesterona
US20090099147A1 (en) * 2007-07-10 2009-04-16 Schwede Wolfgnag Non-steroidal progesterone receptor modulators
DE102007032800A1 (de) * 2007-07-10 2009-01-15 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
DE102007058747A1 (de) * 2007-12-05 2009-06-10 Bayer Schering Pharma Aktiengesellschaft Nichtsteroidale Progesteronrezeptor-Modulatoren
EP2070909A1 (de) * 2007-12-15 2009-06-17 Bayer Schering Pharma AG Nichtsteroidale Progesteronrezeptor-Modulatoren

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19723722A1 (de) * 1997-05-30 1998-12-10 Schering Ag Nichtsteroidale Gestagene
US6245804B1 (en) * 1997-05-30 2001-06-12 Schering Aktiengesellschaft Nonsteroidal gestagens
ES2276038T3 (es) * 2002-01-14 2007-06-16 Boehringer Ingelheim Pharmaceuticals Inc. Mimeticos de glucocorticoides, metodos para su obtencion, formulaciones farmaceuticas que los contienen y usos de los mismos.
EP1344776A1 (en) * 2002-03-11 2003-09-17 Schering Aktiengesellschaft 5- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -phtalide and 6- 2-hydroxy-3-[1-(3-trifluoromethylphenyl)-cyclopropyl]-propionylamino -4-methyl-2,3-benzoxazin-1-one derivatives with progesterone receptor modulating activity for use in fertility control, hormone replacement therapy and the treatment of gynecological disorders
US20050090559A1 (en) * 2003-07-01 2005-04-28 Markus Berger Heterocyclically-substituted pentanol derivatives, process for their production and their use as anti-inflammatory agents
BRPI0412231A (pt) * 2003-07-01 2006-08-22 Schering Ag derivados de pentanol substituìdos heterociclicamente, processos para a sua preparação e sua aplicação como inibidores de inflamação

Also Published As

Publication number Publication date
UY29625A1 (es) 2007-01-31
DOP2006000147A (es) 2006-12-31
EP1895999A1 (en) 2008-03-12
CA2612161A1 (en) 2007-03-01
PE20070324A1 (es) 2007-04-12
DE102005030293A1 (de) 2007-01-04
JP2008543906A (ja) 2008-12-04
US20060293317A1 (en) 2006-12-28
GT200600270A (es) 2008-05-05
AR054803A1 (es) 2007-07-18
WO2007022824A1 (en) 2007-03-01

Similar Documents

Publication Publication Date Title
MX2007014132A (es) Compuestos de diarilhidantoina.
SG149867A1 (en) Selective estrogen receptor modulators for the treatment of vasomotor symptoms
ATE469895T1 (de) Cgrp-rezeptorantagonisten
UA98138C2 (ru) Производные бензамида как модуляторы фолликулостимулирующего гормона
EP1962838A4 (en) Farnesoid X RECEPTOR AGONISTS
TNSN08373A1 (en) Azolopyrimidines as inhibitors of cannabinoid 1 activity
TW200633708A (en) Thieno-pyridine derivatives as gaba-b allosteric enhancers
MXPA06014798A (es) Antagonistas del receptor de hormona para liberar gonadotropina.
MY144622A (en) Agents for preventing and treating disorders involving modulation of the ryr receptors
MX2010001378A (es) Uso terapeutico de anticuerpos del receptor anti-tweak.
IL193479A0 (en) Modulators of muscarinic receptors
WO2009002802A3 (en) Liquiritigenin and derivatives as selective estrogen receptor beta agonists
CL2011000570A1 (es) Compuestos derivados de 3-(4-ciano-fenil)-pirazol-5-carboxamida, moduladores del receptor de progesterona; composicion farmaceutica; y su uso para el tratamiento de endometriosis, fibromiomas uterinos, dismenorrea primaria o secundaria, entre otras.
TW200631947A (en) Crystal forms of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1, 3-benzoxazol-5-ol
MX2009009415A (es) Compuestos de tetrahidroisoquinolina como moduladores del receptor h3 de la histamina.
TW200726461A (en) Use of non-steroidal progesterone receptor modulators
CU24106B1 (es) Compuestos derivados de 6,7-dihidro-5h-benzo[7]anulenos
MA33190B1 (fr) Composes pour le traitement de troubles metaboliques
PL1989218T3 (pl) Pochodne 17-fosforosteroidów użyteczne jako modulatory receptora progesteronowego
MX2007008158A (es) Tratamiento de trastornos por el virus de hepatitis c.
MY157425A (en) Substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
TW200738665A (en) Nonsteroidal progesterone receptor modulators
PA8771801A1 (es) Heterociclos sulfonilados utiles para la modulacion del receptor de progesterona
ATE338763T1 (de) Progesteronrezeptormodulatoren mit erhöhter antigonadotroper aktivität für die weibliche fertilitätskontrolle und hormonersatztherapie
IL189974A0 (en) Benzimidazole derivatives and their use for modulating the gabaa receptor complex